GWMIA
TCRT icon

Global Wealth Management Investment Advisory’s Alaunos Therapeutics TCRT Stock Holding History

Global Wealth Management Investment Advisory’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3
Closed -$2K – 663
2019
Q4 		$2K Hold
3
– – ﹤0.01% 531
2019
Q3 		$2K Hold
3
– – ﹤0.01% 541
2019
Q2 		$3K Buy
+3
New +$2.06K ﹤0.01% 519
2019
Q1 		– Sell
-7
Closed -$2K – 762
2018
Q4 		$2K Buy
+7
New +$2.77K ﹤0.01% 604

Other funds holding TCRT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
Discovery Capital Management
Discovery Capital Management South Norwalk, Connecticut $2.41B AUM 286.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Global Wealth Management Investment Advisory's TCRT Position: Q1 2020 in Review

Global Wealth Management Investment Advisory sold out of Alaunos Therapeutics (TCRT) in Q1 2020, closing a stake of 3 shares — an estimated $2K sold.

Global Wealth Management Investment Advisory first reported a position in TCRT in Q4 2018 and held it in 4 quarters. The position peaked at $3K in Q2 2019. 146 funds tracked by Wall St. Rank hold TCRT as of Q1 2020.

  • Global Wealth Management Investment Advisory reported no remaining Alaunos Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Global Wealth Management Investment Advisory sold 3 Alaunos Therapeutics shares in Q1 2020, an estimated $2K.
  • Global Wealth Management Investment Advisory first reported a position in Alaunos Therapeutics in Q4 2018 and held it in 4 quarters.
  • Global Wealth Management Investment Advisory's Alaunos Therapeutics position peaked at $3K in Q2 2019.
  • 146 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2020.

Based on Global Wealth Management Investment Advisory's 13F filing for Q1 2020, filed 14 May 2020.